Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica

N/ACompletedNCT00541476

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.746 enrolled

Overview

The purpose of this study is to obtain more data about efficacy and safety of the study drug Lyrica.

Study Type

OBSERVATIONAL

Enrollment

746

Conditions

Neuralgia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of peripheral or central neuropathic pain Exclusion Criteria: * None. Patients recruited by physician decision. Patient's personal data are not collected.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.